Structural Isomer Differentiation

Structural isomer differentiation distinguishes positional arrangement variants affecting pharmacology. Ortho, meta, and para isomers exhibit different activity. Branched versus unbranched variations affect metabolism. Regulatory specifications mandate isomer identification. Cross-contamination assessment prevents isomer mixture.

Analytical methods separate structural isomers. Specification compliance monitoring confirms purity. Manufacturing process controls maintain structural identity. Regulatory submissions justify isomer selection. Post-approval monitoring confirms structural identity.